• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小浸润将卵巢浆液性交界性肿瘤与1级浸润性癌联系起来。

Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.

作者信息

Hogg Russell, Scurry James, Kim Soo-Nyung, Friedlander Michael, Hacker Neville

机构信息

Gynaecological Cancer Centre, Royal Hospital for Women, Sydney, Australia.

出版信息

Gynecol Oncol. 2007 Jul;106(1):44-51. doi: 10.1016/j.ygyno.2007.01.054. Epub 2007 Apr 27.

DOI:10.1016/j.ygyno.2007.01.054
PMID:17467045
Abstract

OBJECTIVES

Ovarian serous borderline tumor (SBT) and grade 1 (low grade) serous carcinoma are closely related, but, unlike SBT which has been well studied, there have been few studies looking primarily at grade 1 serous carcinoma. The objective of this study was to better understand the relationship between serous borderline tumors and grade 1 serous carcinomas.

METHODS

We performed a clinicopathologic review of 46 women with SBT and 16 with grade 1 serous carcinoma.

RESULTS

Thirteen of forty-six (28%) SBTs had a micropapillary pattern, 12/46 (26%) had evidence of microinvasion and 19/46 (41%) had extraovarian implants, of which 1/19 (5%) was invasive. Three of forty-six (7%) of SBTs recurred, all of which were originally advanced stage. No patient with a microinvasive SBT recurred. The 16 grade 1 serous carcinomas divided into those with evidence of coexisting SBTs (5 cases) and those without (11 cases). Nine of sixteen (56%) carcinomas recurred, comprising 5/5 with SBT and 4/11 without. All patients had advanced stage at diagnosis. Microinvasion, invasive implants and recurrences all showed qualitative histologic resemblance to carcinoma. There were no micropapillary areas in any of the carcinomas, although cribriform pattern was seen in these tumors.

CONCLUSIONS

Advanced stage at diagnosis was the most important prognostic marker in patients with SBT. Although a micropapillary pattern was common, it did not adversely affect prognosis per se, but was associated with a higher stage. A micropapillary pattern was not seen adjacent to microinvasion or in association with grade 1 serous carcinoma. Microinvasion was common but, in our series, did not appear to worsen the prognosis. Grade 1 serous carcinoma was less common than SBT and had a more unfavorable prognosis. The qualitative histologic similarity between microinvasion, invasive implants, recurrences and grade 1 serous carcinoma suggests that microinvasion represents early invasion and is not just another histologic pattern of SBT. We speculate that some invasive implants and recurrences may be peritoneal grade 1 serous carcinoma.

摘要

目的

卵巢浆液性交界性肿瘤(SBT)与1级(低级别)浆液性癌密切相关,但与已得到充分研究的SBT不同,主要针对1级浆液性癌的研究较少。本研究的目的是更好地了解浆液性交界性肿瘤与1级浆液性癌之间的关系。

方法

我们对46例患有SBT的女性和16例患有1级浆液性癌的女性进行了临床病理回顾。

结果

46例SBT中有13例(28%)具有微乳头模式,12/46(26%)有微浸润证据,19/46(41%)有卵巢外种植,其中1/19(5%)为浸润性。46例SBT中有3例(7%)复发,均为晚期。微浸润性SBT患者均未复发。16例1级浆液性癌分为有并存SBT证据的(5例)和无并存SBT证据的(11例)。16例中有9例(56%)癌复发,包括5/5有SBT的和4/11无SBT的。所有患者诊断时均为晚期。微浸润、浸润性种植和复发在组织学上均与癌有定性相似性。所有癌中均无微乳头区域,尽管这些肿瘤可见筛状模式。

结论

诊断时为晚期是SBT患者最重要的预后标志物。虽然微乳头模式常见,但本身并不对预后产生不利影响,而是与更高分期相关。微浸润或与1级浆液性癌相关处未见微乳头模式。微浸润常见,但在我们的系列研究中似乎并未使预后恶化。1级浆液性癌比SBT少见,预后更差。微浸润、浸润性种植、复发与1级浆液性癌在组织学定性上的相似性表明,微浸润代表早期浸润,而不仅仅是SBT的另一种组织学模式。我们推测一些浸润性种植和复发可能是腹膜1级浆液性癌。

相似文献

1
Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.微小浸润将卵巢浆液性交界性肿瘤与1级浸润性癌联系起来。
Gynecol Oncol. 2007 Jul;106(1):44-51. doi: 10.1016/j.ygyno.2007.01.054. Epub 2007 Apr 27.
2
Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.卵巢浆液性交界性肿瘤:137例长期随访研究,其中18例具有微乳头模式,20例有微浸润。
Am J Surg Pathol. 2002 Sep;26(9):1111-28. doi: 10.1097/00000478-200209000-00002.
3
Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.低恶性潜能卵巢浆液性肿瘤(交界性肿瘤)的间质浸润模式:对间质微浸润概念的重新评估
Am J Surg Pathol. 2006 Oct;30(10):1209-21. doi: 10.1097/01.pas.0000213299.11649.fa.
4
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
5
[Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].卵巢交界性肿瘤和癌的临床病理分析及细胞周期蛋白D1和p53的表达
Zhonghua Fu Chan Ke Za Zhi. 2007 Apr;42(4):227-32.
6
Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.具有间质微浸润的低恶性潜能卵巢浆液性肿瘤中的淋巴管浸润:一项病例对照研究。
Am J Surg Pathol. 2008 Feb;32(2):261-8. doi: 10.1097/PAS.0b013e318141fc7a.
7
[Diagnostic difficulties in serous "borderline" tumors of the ovary].[卵巢浆液性“交界性”肿瘤的诊断难点]
Magy Onkol. 2009 Mar;53(1):23-31. doi: 10.1556/MOnkol.53.2009.1.4.
8
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.硒结合蛋白 1 表达的进行性丧失与卵巢浆液性交界性肿瘤和低级别浆液性癌中上皮增殖和乳头复杂性的增加相关。
Hum Pathol. 2010 Feb;41(2):255-61. doi: 10.1016/j.humpath.2009.07.019. Epub 2009 Nov 6.
9
Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.浆液性交界性肿瘤细分为非典型增生性肿瘤和非浸润性低级别癌的长期行为:一项基于人群的942例临床病理研究
Am J Surg Pathol. 2017 Jun;41(6):725-737. doi: 10.1097/PAS.0000000000000824.
10
Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.对两种用于国际妇产科联盟(FIGO)III期卵巢和腹膜浆液性癌的二元分级系统进行测试。
Gynecol Oncol. 2006 Nov;103(2):703-8. doi: 10.1016/j.ygyno.2006.05.030. Epub 2006 Jul 7.

引用本文的文献

1
Clinical Characteristics, Surgical Management, and Outcomes of Borderline Ovarian Tumours: A Retrospective Observational Study from North East London.卵巢交界性肿瘤的临床特征、手术治疗及预后:来自伦敦东北部的一项回顾性观察研究
J Clin Med. 2025 Mar 30;14(7):2383. doi: 10.3390/jcm14072383.
2
Fertility-sparing surgery versus radical surgery for micropapillary serous borderline ovarian tumours: a systematic review protocol.保留生育功能手术与激进手术治疗微乳头状浆液性交界性卵巢肿瘤:系统评价方案。
BMJ Open. 2024 Nov 12;14(11):e077503. doi: 10.1136/bmjopen-2023-077503.
3
Targeting BRAF pathway in low-grade serous ovarian cancer.
针对低级别浆液性卵巢癌中的 BRAF 通路。
J Gynecol Oncol. 2024 Jul;35(4):e104. doi: 10.3802/jgo.2024.35.e104. Epub 2024 May 14.
4
Management of Borderline ovarian tumors (BOT): results of a retrospective, single center study in Switzerland.交界性卵巢肿瘤(BOT)的治疗:瑞士单中心回顾性研究结果。
J Ovarian Res. 2023 Jan 23;16(1):20. doi: 10.1186/s13048-023-01107-3.
5
A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis.一例罕见的伴有脑转移的卵巢浆液性交界性肿瘤
Case Rep Pathol. 2019 May 22;2019:2954373. doi: 10.1155/2019/2954373. eCollection 2019.
6
Histopathological Patterns of Microinvasion in Ovarian Serous Borderline Tumors.卵巢浆液性交界性肿瘤微浸润的组织病理学模式
Curr Health Sci J. 2018 Jan-Mar;44(1):19-22. doi: 10.12865/CHSJ.44.01.03. Epub 2018 Jan 6.
7
Advanced stage micropapillary serous borderline ovarian tumor in a postmenopausal woman: a case report.一名绝经后妇女的晚期微乳头浆液性卵巢交界性肿瘤:病例报告
J Turk Ger Gynecol Assoc. 2012 Sep 1;13(3):208-11. doi: 10.5152/jtgga.2012.30. eCollection 2012.
8
Cyberknife radiotherapy and anastrozole for the treatment of advanced progressive low-grade papillary serous ovarian carcinoma: A case report.射波刀放射治疗联合阿那曲唑治疗晚期进展性低级别浆液性乳头状卵巢癌:一例报告
Gynecol Oncol Case Rep. 2013 Sep 21;6:42-4. doi: 10.1016/j.gynor.2013.09.002. eCollection 2013.
9
Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.免疫组织化学分析凋亡-抗凋亡蛋白(p53、p21、bax、bcl-2)、c-kit、端粒酶和金属硫蛋白在良性、交界性和恶性浆液性和黏液性卵巢肿瘤中的诊断辅助作用。
Diagn Pathol. 2012 Sep 20;7:124. doi: 10.1186/1746-1596-7-124.